Abstract
Febrile neutropenia is an oncologic emergency that is seen in patients receiving chemotherapy. It is more commonly noted in hematologic malignancies, although it can be observed in solid tumor cancers. Management involves prompt infectious workup, determination of high or low risk using the Multinational Association for Supportive Care in Cancer risk index score, and initiation of empiric antimicrobials in the inpatient or outpatient setting. Close monitoring for organ dysfunction and worsening clinical status is essential. Nurse practitioners must identify risk factors, signs, and symptoms of febrile neutropenia and understand the proper management strategies for both high- and low-risk patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
